Literature DB >> 12585168

[Clinical observation on colquhounia root tablet in treating lipid metabolism disturbance secondary to nephrotic syndrome].

Xin-lin Wu1, Jun-biao Li, Sui-lin Mo.   

Abstract

OBJECTIVE: To study the effect of Colquhounia root tablet (CRT) in treating nephrotic syndrome with sequential lipid metabolism disorder (NS-LMD).
METHODS: The 96 patients with NS-LMD were randomly divided into two groups, the 60 cases in the treated group treated with CRT and the 36 cases in the control group treated with hormone or cytotoxic medicine. The curative effect and the related indexes were determined before and after treatment.
RESULTS: After six months treatment, the general effective rate in the treated group was 88. 33%, which was markedly higher than that in the control group (69.44%, P < 0.05). The levels of the treated group in ameliorating lipid metabolism disorder and renal dysfunction were also higher than those in the control group (P < 0.05).
CONCLUSION: CRT could improve NS-LMD, improve renal function, eliminate urinary protein and increase plasma albumin. It is highly effective with low toxicity and safe.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12585168

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Colquhounia Root Tablet Protects Rat Pulmonary Microvascular Endothelial Cells against TNF-α-Induced Injury by Upregulating the Expression of Tight Junction Proteins Claudin-5 and ZO-1.

Authors:  Wenjie Zhou; Guocui Shi; Jijia Bai; Shenmao Ma; Qinfu Liu; Xigang Ma
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-18       Impact factor: 2.629

2.  Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.

Authors:  Fei Li; Dan Han; Bo Wang; Wentao Zhang; Yan Zhao; Jing Xu; Liesu Meng; Kuanhou Mou; Shemin Lu; Wenhua Zhu; Yan Zhou
Journal:  Mediators Inflamm       Date:  2022-01-11       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.